MedTrace Logo

Randomized Study of Plasmapheresis or Human Immunoglobulin Infusion in Childhood Guillain-Barre Syndrome

NCT00004833 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 170

Last updated 2015-04-07

No results posted yet for this study

Summary

OBJECTIVES:

I. Compare the efficacy of plasmapheresis and human immunoglobulin infusion in minimizing morbidity and augmenting the pace of recovery in children with Guillain-Barre syndrome.

II. Compare the potential risks, in terms of treatment related side effects and adverse clinical outcome, between these two treatment modalities.

Conditions

  • Guillain-Barre Syndrome

Interventions

DRUG

Immune globulin

Sponsors & Collaborators

  • Emory University

    lead OTHER

Principal Investigators

  • John T. Sladky · Emory University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT

Eligibility

Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1995-07-31
Completion
2002-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00004833 on ClinicalTrials.gov